BIOTE CORP - COMPANY EXPECTS $1.3M CHARGE FOR FOURTH QUARTER DUE TO RECALL OF SPECIFIC LOTS OF HORMONE PELLETS - SEC FILING
BIOTE CORP - ADDITIONAL RECALL COSTS IN 2026 ESTIMATED AT $1.0M - SEC FILING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.